Pitt Shield

A novel ultrasound-responsive cluster bomb system for efficient siRNA delivery in brain.

Authors: Guo T, Dong F, Yin J, Wang X, Min P, Zhang J, Cheng H, Zhang J

RNA-based therapeutics using RNA interference have become a research hotspot for brain tumors and neurodegenerative diseases with the advancement of nanocarrier delivery technology. However, even with specific modifications, RNA-loaded nanoparticles face significant challenges in effectively crossing the blood-brain barrier (BBB) to achieve precise delivery of therapeutic agents to the brain. Focused ultrasound combined with microbubbles and nanodroplets has emerged as a promising approach for temporarily opening the BBB. However, the low drug loading capacity and fixed stimulation focus of these methods limit their integration with current nano-drug delivery systems. Herein, we introduced a fluorinated surfactant and developed an ultrasound-responsive siRNA delivery carrier that contains nanodroplets loaded with siRNA-carrying nanoparticles (siRNA@NP@ND), termed as "ultrasound-responsive 'cluster bomb' nanoplatform". Under precise and flexible guidance and stimulation through a programmable diagnostic ultrasound, siRNA@NP@ND demonstrated over a seventy-fold increase in efficiency for delivering siRNA to the mouse brain. Additionally, Evans blue staining and hematological analysis indicated that ultrasound-triggered cavitation could reversibly open the BBB for up to 48 h without causing significant immune or inflammatory responses. The minor intracranial hemorrhage resulting from this process was also shown to be recoverable. Our research provides an advanced and controllable delivery platform for gene therapy of intracranial central nervous system diseases.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To develop and validate an ultrasound-responsive 'cluster bomb' nanoplatform that transiently opens the blood–brain barrier and enables efficient, targeted delivery of siRNA to the brain.
Animal model / Human subject BALB/c Mouse; strain not specified; age not specified; sex not specified
Disease model Healthy
MRI or image guidance method programmable diagnostic ultrasound
Targeted brain region(s) Tumor-Prone Brain Region In The Hemisphere
Cargo name and characteristics siRNA (small interfering RNA), an RNA therapeutic loaded into nanoparticles (siRNA-carrying nanoparticles) encapsulated within ultrasound-responsive nanodroplets (siRNA@NP@ND)
Route of administration Intravenous

Outcomes and Safety

Summary of Outcomes An ultrasound-responsive 'cluster bomb' (siRNA@NP@ND) increased siRNA delivery to the mouse brain ~70.8-fold versus siRNA@NP and enabled reversible BBB opening for up to 48 h with minimal immune/inflammatory responses and only recoverable minor intracranial hemorrhage. Ultrasound guidance enabled localized stimulation and multiple acoustic pressures evaluated, with 3.8 MPa as a safer effective setting
Duration of biological effect 48 h
Safety-related matter Evans blue staining and hematological analysis showed ultrasound-triggered BBB opening was reversible for up to 48 h without significant immune or inflammatory responses, although a minor intracranial hemorrhage was observed and reported to be recoverable. Nanodroplet encapsulation mitigated the inherent cytotoxicity of cationic siRNA@NP, but the authors note that long-term safety and immunogenicity remain insufficiently assessed for clinical translation.

Brain Region

Ultrasound Parameters

Ultrasound instrument Programmable diagnostic ultrasound
FUS Frequency 1 MHz
FUS Pressure 3.8 Mpa
Duration of a single FUS session 1 min
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency Single

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search